Medication Error Reporting Protocol
Contents |
DataSetsGEO ProfilesGSSGTRHomoloGeneMedGenMeSHNCBI Web SiteNLM CatalogNucleotideOMIMPMCPopSetProbeProteinProtein ClustersPubChem BioAssayPubChem CompoundPubChem SubstancePubMedPubMed HealthSNPSparcleSRAStructureTaxonomyToolKitToolKitAllToolKitBookToolKitBookghUniGeneSearch termSearch Browse Titles Limits Advanced medication error reporting procedure Help NCBI Bookshelf. A service of the National medication error what to do after Library of Medicine, National Institutes of Health.Hughes RG, editor. Patient Safety and Quality: reporting medication errors in nursing An Evidence-Based Handbook for Nurses. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Apr. Patient Safety and Quality: An consequences of medication errors for nurses Evidence-Based Handbook for Nurses.Show detailsHughes RG, editor.Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Apr.ContentsSearch term < PrevNext > Chapter 35Error Reporting and DisclosureZane Robinson Wolf; Ronda G. Hughes.Author InformationZane Robinson Wolf;1 Ronda G. Hughes.21 Zane Robinson Wolf, Ph.D., R.N., F.A.A.N.,
Drug Errors In Nursing What To Do
dean and professor, La Salle University School of Nursing and Health Sciences. E-mail: ude.ellasal@flow2 Ronda G. Hughes, Ph.D., M.H.S., R.N., senior health scientist administrator, Agency for Healthcare Research and Quality. E-mail: vog.shh.qrha@sehguH.adnoRBackgroundThis chapter examines reporting of health care errors (e.g., verbal, written, or other form of communication and/or recording of near miss and patient safety events that generally involves some form of reporting system) and these events’ disclosure (e.g., communication of errors to patients and their families), including the ethical aspects of error-reporting mechanisms. The potential benefits of intrainstitutional and Web-based databases might assist nurses and other providers to prevent similar hazards and improve patient safety. Clinicians’ fears of lawsuits and their self-perceptions of incompetence could be dispelled by organizational cultures emphasizing safety rather than blame. Thi
In Username or Email * Password * Forgot Password? Remember Me Don't have an account? Create New Account Home New This Week Measure Summaries By Measure Domain
Medication Error Reporting Form
By Measurement Setting By Organization By MeSH Tag In Progress Archive All medication errors made by nurses Summaries Expert Commentaries Matrix Tool Submit Measures Help &About Measure Summary NQMC:004963 Feb 2009 Medication errors: does the actions to take in the event of a medication error hospital have a protocol for detection, recording and reporting of medication errors that involves the pharmacy service? Developer Source Status Classification Grupo de Investigación sobre Gestión de la Calidad en https://www.ncbi.nlm.nih.gov/books/NBK2652/ Servicios de Salud, University of Murcia, under contract to the Spanish Ministry of Health Get Alerts Ministry of Health. Safe practices indicators project: background, summary of methods and measurement strategies. Madrid: Ministry of Health; 2009 Feb 20. 97 p. This is the current release of the measure. The measure developer reaffirmed the currency of this measure in April 2016. https://www.qualitymeasures.ahrq.gov/summaries/summary/27517/medication-errors-does-the-hospital-have-a-protocol-for-detection-recording-and-reporting-of-medication-errors-that-involves-the-pharmacy-service Measure Hierarchy Safe Practices Indicators Project > Matching Healthcare Needs with Service Delivery Capability > Hospital Pharmacy Staffing and Role Age Group Does not apply to this measure UMLS Concepts (what is this?) MSH Adverse Drug Reaction Reporting Systems , Medication Errors , Pharmacy Service, Hospital MTH Medication Error SNOMEDCT_US Medication error (398240004) Sections Measure Domain Brief Abstract Evidence Supporting the Measure State of Use of the Measure Application of the Measure in its Current Use National Strategy for Quality Improvement in Health Care Institute of Medicine (IOM) National Health Care Quality Report Categories Data Collection for the Measure Computation of the Measure Identifying Information Disclaimer Download .PDF 85.7 kb Word Document 48.4 kb .XML 23.1 kb Share Facebook Twitter Linkedin Email Cite Citation: National Quality Measures Clearinghouse (NQMC). Measure summary: Medication errors: does the hospital have a protocol for detection, recording and reporting of medication errors that involves the pharmacy service?. In: National Quality Measures Clearinghouse (NQMC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2009 Feb 20. [cited 2016 Oct 20]. Av
Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products Drugs Home Drugs Drug Safety and Availability Medication Errors Medication http://www.fda.gov/drugs/drugsafety/medicationerrors/ Errors Related to Drugs Share Tweet Linkedin Pin it More sharing options Linkedin Pin it Email Print Within the Center for Drug Evaluation and Research (CDER), the Division of Medication Error Prevention and Analysis (DMEPA) reviews medication error reports on marketed human drugs including prescription drugs, generic drugs, and over-the-counter drugs. DMEPA uses the National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP) definition of a medication medication error error. Specifically, a medication error is "any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems, including prescribing; order communication; product labeling, packaging, and nomenclature; compounding; dispensing; distribution; administration; education; monitoring; and use."DMEPA includes a medication error reporting medication error prevention program staffed with healthcare professionals. Among their many duties, program staff review medication error reports sent to MedWatch, evaluate causality, and analyze the data to provide solutions to reduce the risk of medication errors to industry and others at FDA.Additionally, DMEPA prospectively reviews proprietary names, labeling, packaging, and product design prior to drug approval to help prevent medication errors.Although DMEPA encourages manufacturers to perform their due diligence when naming their drug products and we strive to avoid approving confusing proprietary names for drug products, there are cases of adverse events where a name of a marketed product is identified as a source of confusion and error. Therefore, we continue to encourage healthcare providers, patients and consumers to report all medication errors to MedWatch so that we can be made aware of potential problems related to drug names and the Agency can provide effective interventions that will minimize further errors. In some situations, changing a proprietary name while the product is marketed may be necessary to address safety issues resulting from the name confusion errors.DMEPA also works closely with federal partners, patient safety organizations such as Institute for Safe Medication Practices (ISMP), standard setting organizations such as the United States Pharmacopeia (USP), a